SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 93 filers reported holding SAGENT PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $3,980,000 | -64.4% | 327,021 | -53.5% | 0.01% | -58.3% |
| Q4 2015 | $11,193,000 | +22.6% | 703,536 | +18.1% | 0.02% | +33.3% |
| Q3 2015 | $9,129,000 | +21.8% | 595,491 | +93.2% | 0.02% | +28.6% |
| Q2 2015 | $7,494,000 | -1.2% | 308,281 | -5.5% | 0.01% | 0.0% |
| Q1 2015 | $7,583,000 | -19.0% | 326,169 | -12.6% | 0.01% | -30.0% |
| Q4 2014 | $9,367,000 | +45.5% | 373,058 | +80.3% | 0.02% | +25.0% |
| Q3 2014 | $6,437,000 | -38.7% | 206,963 | -49.0% | 0.02% | -44.8% |
| Q2 2014 | $10,494,000 | -24.8% | 405,799 | -32.1% | 0.03% | -27.5% |
| Q1 2014 | $13,962,000 | +57.1% | 597,431 | +70.6% | 0.04% | +42.9% |
| Q4 2013 | $8,886,000 | -12.1% | 350,136 | -29.4% | 0.03% | -15.2% |
| Q3 2013 | $10,111,000 | +176.9% | 495,617 | +184.7% | 0.03% | +200.0% |
| Q2 2013 | $3,652,000 | – | 174,069 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 462,824 | $7,364,000 | 8.63% |
| HealthCor Management, L.P. | 1,750,000 | $27,843,000 | 1.69% |
| ACUTA CAPITAL PARTNERS, LLC | 144,667 | $2,302,000 | 1.10% |
| THB ASSET MANAGEMENT | 615,546 | $9,793,000 | 1.05% |
| Penn Capital Management Company, LLC | 1,399,205 | $22,261,000 | 0.98% |
| Tamarack Advisers, LP | 450,000 | $7,160,000 | 0.94% |
| Piermont Capital Management Inc. | 139,020 | $2,212,000 | 0.70% |
| JW Asset Management, LLC | 101,630 | $1,617,000 | 0.60% |
| SECTORAL ASSET MANAGEMENT INC | 810,362 | $12,893,000 | 0.55% |
| Glacier Peak Capital LLC | 50,000 | $796,000 | 0.51% |